SEARCH

SEARCH BY CITATION

References

  • 1
    Tack J, Talley NJ, Camilleri M et al. Functional gastroduodenal disorders. Gastroenterology 2006; 130: 146679.
  • 2
    Stewart A, Greenfield S, Hays R et al. Functional status and well-being of patients with chronic conditions. JAMA 1989; 262: 9071013.
  • 3
    Maldonado JE, Gregg JA, Green PA, Brown AL Jr. Chronic idiopathic intestinal pseudo-obstruction. Am J Med 1970; 49: 20312.
  • 4
    Stanghellini V, Corinaldesi R, Barbara L. Pseudo-obstruction syndromes. Baillieres Clin Gastroenterol 1988; 2: 22554.
  • 5
    Di Lorenzo C. Pseudo-obstruction: current approaches. Gastroenterology 1999; 116: 9807.
  • 6
    Wingate D, Hongo M, Kellow J, Lindenberg G, Smout A. Disorders of gastrointestinal motility: towards a new classification. J Gastroenterol Hepatol 2002; 17(Suppl): S114.
  • 7
    Rosa-E-Silva L, Gerson L, Davila M, Triadafilopoulus G. Clinical, radiologic, and manometric characteristics of chronic intestinal dysmotility: the Stanford experience. Clin Gastroenterol Hepatol 2006; 4: 86673.
  • 8
    Iwarzon M, Gardulf A, Lindberg G. Functional status, health-related quality of life and symptom severity in patients with chronic intestinal pseudo-obstruction and enteric dysmotility. Scand J Gastroenterol 2009; 44: 7007.
  • 9
    Quigley EM, Deprez PH, Hellstrom P et al. Ambulatory intestinal manometry: a consensus report on its clinical role. Dig Dis Sci 1997; 42: 2395400.
  • 10
    Husebye E. The patterns of small bowel motility: physiology and implications in organic disease and functional disorders. Neurogastroenterol Mot 1999; 11: 14161.
  • 11
    Talley NJ, Phillips SF, Melton J 3rd, Wiltgen C, Zinsmeister AR. A patient questionnaire to identify bowel diseease. Ann Intern Med 1989; 111: 6714.
  • 12
    Barbara G, Stanghellini V, De Giorgio R et al. Activated mast cells in proximity to colonic nerves correlate with abdominal pain in irritable bowel syndrome. Gastroenterology 2004; 126: 693702.
  • 13
    Stanghellini V, Cogliandro RF, De Giorgio R et al. Natural history of chronic idiopathic intestinal obstruction in adults: a single center study. Clin Gastroenterol Hepatol 2005; 3: 44958.
  • 14
    Drossman D. The functional gastrointestinal disorders and the Rome II process. Gut 1999; 45(Suppl II): II15.
  • 15
    Association AP. Diagnostic and statistical manual of Mental Disorders, 4th edn. Washinghton DC: American Psychiatric Association, 1994.
  • 16
    Pierangeli G, Parchi P, Barletta G, Chiogna M, Lugaresi E, Cortelli P. Power spectral analysis of heart rate and diastolic blood pressure variability in migraine with and without aura. Cephalalgia 1997; 17: 75660.
  • 17
    Stanghellini V, Camilleri M, Malagelada JR. Chronic idiopathic intestinal pseudo-obstruction: clinical and intestinal manometric findings. Gut 1987; 28: 512.
  • 18
    Malagelada JR, Camilleri M, Stanghellini V. Manometric Diagnosis of Gastrointestinal Motility Disorders. New York: Thieme, 1986.
  • 19
    Malagelada JR, Stanghellini V. Manometric evaluation of functional upper gut symptoms. Gastroenterology 1985; 88: 122331.
  • 20
    Camilleri M, Stanghellini V, Azpiroz F. Small bowel manometry. Dig Dis Sci 1997; 42: 24012.
  • 21
    Kellow JE. Small intestine: normal function and clinical disorders. manometry. In: Schuster MM, Crowell MD, Koch KL, eds. Schuster Atlas of Gastrointestinal Motility in Health and Disease. Hamilton-London: BC Decker, 2002: 21936.
  • 22
    Apolone G, Mosconi P, Ware JE Jr. Questionario sullo stato di salute SF-36. Manuale d’uso e guida all’interpretazione dei risultati. In: Guerini ed. Milano, Italia: Associati, 1997: 1227.
  • 23
    Ware JE, Sherbourne C. The MOS 36-item short form health survey (SF-36) 1: conceptual framework and item selection. Med Care 1992; 30: 47383.
  • 24
    Luscombe FA. Health-related quality of life and associated psycosocial factors in irritable bowel syndrome: a review. Qual Life Res 2000; 9: 16176.
  • 25
    Ware JE Jr, Gandek B. Overview of the SF-36 Health Survey and the International Quality of Life Assessment (IQOLA) Project. J Clin Epidemiol 1998; 51: 90312.
  • 26
    Drossman DA. The functional gastrointestinal disorders and the Rome III process. In: Drossman DA, Corazziari E, Delvaux M, Spiller RC, Talley NJ, Thompson WG et al. , eds. Rome III. The Functional Gastrointestinal Disorders, 2nd edn. McLean, VA: Degnon Associates, Inc., 2006: 129.
  • 27
    SPSS Inc., SPSS® 13.0 command syntax reference. Chicago, IL, USA. 2004. http://www-01.ibm.com/software/analytics/spss/ (accessed 29 August 2011).
  • 28
    Lembo A, Ameen VZ, Drossman DA. Irritable bowel syndrome: toward an understanding of severity. Clin Gastroenterol Hepatol. 2005; 3: 71725.
  • 29
    Jones MP, Talley NJ, Eslick GD, Dubois D, Tack J. Community subgroups in dyspepsia and their association with weight loss. Am J Gastroenterol 2008; 103: 205160.
    Direct Link:
  • 30
    Abell TL, Camilleri M, DiMagno EP, Hench VS, Zinsmeister AR, Malagelada JR. Long-term efficacy of oral cisapride in symptomatic upper gut dysmotility. DDS 1991; 36: 61620.
  • 31
    Ford AC, Veldhuyzen van Zanten SJ, Rodgers CC, Talley NJ, Vakil NB, Moayyedi P. Diagnostic utility of alarm features for colorectal cancer: systematic review and meta-analysis. Gut 2008; 57: 154553.
  • 32
    Vakil N, Moayyedi P, Fennerty MB, Talley NJ. Limited value of alarm features in the diagnosis of upper gastrointestinal malignancy: systematic review and meta-analysis. Gastroenterology 2006; 131: 390401.
  • 33
    Soffer EE, Thongsawat S. Small bowel manometry. Short or long recording session? Dig Dis Sci 1997; 42: 8737.
  • 34
    De Giorgio R, Sarnelli G, Corinaldesi R, Stanghellini V. Advances in our understanding of the pathology of chronic intestinal pseudo-obstruction. Gut 2004; 53: 154952.
  • 35
    Simrem M, Svedlund J, Posserud I, Björnsson ES, Abrahamsson H. Health-related quality of life in patients attending a gastroenterology outpatient clinic: functional disorders vs organic diseases. Clin Gastroenterol Hepatol 2006; 4: 18795.
  • 36
    Gralnek I, Hays R, Kilbourne A, Naliboff B, Mayer EA. The impact of irritable bowel syndrome on health-related quality of life. Gastroenterology 2000; 119: 65460.
  • 37
    Frank L, Kleinman L, Rentz A, Ciesla G, Kim JJ, Zacker C. Health-related quality of life associated with irritable bowel syndrome: comparison with other chronic diseases. Clin Ther 2002; 24: 67589.
  • 38
    Dahlof C, Dimenas E. Migraine patients experience poorer subjective well-being/quality of life even between episodes. Cephalagia 1995; 15: 316.
  • 39
    Seres G, Kovacs Z, Kovács A et al. Different associations of health related quality of life with pain, psychologic distress and coping strategies in patients with irritable bowel syndrome and inflammatory bowel disorder. J Clin Psychol Med Settings 2008; 15: 28795.
  • 40
    Lackner J, Gudleski G, Zack M et al. Measuring health-related quality of life in patients with irritable bowel syndrome: can less be more? Psychosom Med 2006; 68: 31220.
  • 41
    Coffin B, Dapoigny M, Cloarec D, Comet D, Dyard F. Relationship between severity of symptoms and quality of life in 858 patients with irritable bowel syndrome. Gastroenterol Clin Biol 2004; 28: 115.
  • 42
    Amouretti M, Le Pen C, Gaudin AF et al. Impact of irritable bowel syndrome (IBS) on health-related quality of life (HRQOL). Gastroenterol Clin Biol 2006; 30: 2416.
  • 43
    Park J, Choi M, Kim Y et al. Quality of life in patients with irritable bowel syndrome in Korea. Qual Life Res 2009; 18: 43546.
  • 44
    Brun-Strang C, Dapoigny M, Lafuma A, Wainsten JP, Fagnani F. Irritable bowel syndrome in France: quality of life, medical management, and costs: the Encoli study. Eur J Gastroenterol Hepatol 2007; 19: 1097103.
  • 45
    Creed F, Ratcliffe J, Fernandez L et al. Health-related quality of life and health care costs in severe, refractory irritable bowel syndrome. Ann Int Med 2001; 134: 8608.
  • 46
    Simren M, Abrahamsson H, Svedlund J, Björnsson ES. Quality of life in patients with irritable bowel syndrome seen in referral centers vs primary care: the impact of gender and predominant bowel pattern. Scand J Gastroenterol 2001; 36: 54552.
  • 47
    Talley NJ, Zinsmeister AR, Melton LJ 3rd. Irritable bowel syndrome in a community: symptom subgroups, risk factors, and health care utilization. Am J Epidemiol 1995; 142: 7683.
  • 48
    Hahn BA, Kirchdoerfer LJ, Fullerton S, Mayer E. Patient-perceived severity of irritable bowel syndrome in relation to, symptoms, health resource utilization and quality of life. Aliment Pharmacol Ther 1997; 11: 5539.
  • 49
    Spiegel BM, Gralnek IM, Bolus R et al. Clinical determinants of Health related Quality of life in patients with irritable bowel syndrome. Arch Intern Med 2004; 164: 177380.